Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of BIAF will decline by -45.06% over the next 2 Weeks and hit $3.62 by Tuesday, September 15, 2026. In that time frame, BIAF's share price is expected to range between $3.04 and $4.23.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Sep 15, 2026 | 3.04 | 3.62 | 4.23 |
| Sep 14, 2026 | 2.88 | 3.46 | 4.04 |
| Sep 11, 2026 | 3.16 | 3.78 | 4.34 |
| Sep 10, 2026 | 3.30 | 3.87 | 4.46 |
| Sep 9, 2026 | 3.53 | 4.07 | 4.61 |
| Sep 8, 2026 | 4.05 | 4.64 | 5.20 |
| Sep 7, 2026 | 3.86 | 4.48 | 5.04 |
| Sep 4, 2026 | 4.23 | 4.79 | 5.41 |
| Sep 3, 2026 | 4.33 | 4.89 | 5.50 |
| Sep 2, 2026 | 4.58 | 5.09 | 5.75 |
BIAF shares rose +44.52% in Tuesday, September 1, 2026's trading session, rising from a previous close of $4.56 to move at $6.59. The stock demonstrated notable intraday movement (see BIAF's key stats for a full breakdown), fluctuating between $6.13 and $8.60, a +40.29% trading range. While recent weeks have seen some volatility, BIAF has managed to secure a +7.42% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 45.64M shares changing hands, 45.61M more than the previous session. This amounted to $300.78M in total market activity.
Will BIAF Continue Its Downward Trend?
According to analyst ratings and projections for BIAF, bioAffinity Technologies, Inc. shares are anticipated to decrease by -55.69%, potentially reaching $4.23 per share by September 15, 2026. Short-term technical indicators for BIAF currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 24 negative trading days within the past 30 sessions. Based on the BIAF stock forecast, now is not the best time to buy BIAF stock because its current trading price is +82.00% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on BIAF covering social and institutional perspectives.
BIAF Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into BIAF's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 39.60% to 54.64%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 40.74%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 43.51%, maintains a neutral outlook for the long term. Insights into BIAF's shareholder base show how institutional investors are positioning themselves during these momentum shifts
bioAffinity Technologies Short-Term Forecasts
BIAF Forecast For Next 5 Days
Our algorithm anticipates bioAffinity Technologies (BIAF) stock could hit $4.69 by Sep 08, 2026. This represents a -28.87% rise from today's price, following a +3.15% change over the past five days.
BIAF Forecast For Next 30 Days
Based on analysis of market trends, the outlook for bioAffinity Technologies, Inc. (BIAF) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $3.55, which would mean a -46.13% decrease from the current price of $6.59. Projections for this period range from a high of $7.72 to a low of $0.32.
BIAF Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for bioAffinity Technologies's price over the next three months point to a drop. BIAF stock is expected to peak at $37.47 on Oct 13, 2026 before potentially dipping to $0.00 on Dec 02, 2026. On average, BIAF is likely to trade around $5.21 in the coming 90 days.
bioAffinity Technologies Stock Forecast 2025
Based on our predictive models, bioAffinity Technologies (BIAF) is expected to trade between $0.00 and $37.47 throughout 2026. This would result in an average price of $5.04, potentially offering investors a -23.52% return from current levels.
bioAffinity Technologies, Inc. Monthly Forecast 2026–2027
September 2026
According to our latest forecast models, bioAffinity Technologies, Inc. (BIAF) is positioned to show a strong performance in September 2026. The price is predicted to move between $0.00 and $33.73, settling at an average of $5.43. This could translate to a -17.60% loss.
October 2026
Based on current market signals, bioAffinity Technologies, Inc. is projected to trend october 2026. We forecast a trading range from $0.00 to $37.47, with a likely average price of $7.42. Investors could expect a potential return of +12.59%.
November 2026
Our predictive algorithms indicate bioAffinity Technologies, Inc. stock may see a shift in November 2026. The expected range spans $0.00–$33.69, with an average target of $2.88. This represents a cautious outlook and a possible loss of -56.30%.
December 2026
Analyzing established trends, bioAffinity Technologies, Inc. looks set to move in December 2026. Projections place the stock between $0.00 and $33.89, averaging around $4.37. This suggests a -33.69% loss from current levels.
January 2027
Market indicators suggest bioAffinity Technologies, Inc. could experience notable changes during January 2027. Prices could fluctuate within $0.00 to $34.95, with a midpoint forecast of $2.53. The stock might deliver a -61.61% loss.
February 2027
Forecasting for February 2027, models estimate that bioAffinity Technologies, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $32.28, averaging $2.34. This signals a cautious trajectory with potential returns around -64.49%.
March 2027
According to our latest forecast models, bioAffinity Technologies, Inc. (BIAF) is positioned to show a strong performance in March 2027. The price is predicted to move between $0.00 and $33.11, settling at an average of $3.78. This could translate to a -42.64% loss.
April 2027
Based on current market signals, bioAffinity Technologies, Inc. is projected to trend april 2027. We forecast a trading range from $0.00 to $33.09, with a likely average price of $2.69. Investors could expect a potential return of -59.18%.
May 2027
Our predictive algorithms indicate bioAffinity Technologies, Inc. stock may see a shift in May 2027. The expected range spans $0.00–$30.18, with an average target of $2.79. This represents a cautious outlook and a possible loss of -57.66%.
June 2027
Analyzing established trends, bioAffinity Technologies, Inc. looks set to move in June 2027. Projections place the stock between $0.00 and $34.33, averaging around $1.49. This suggests a -77.39% loss from current levels.
July 2027
Market indicators suggest bioAffinity Technologies, Inc. could experience notable changes during July 2027. Prices could fluctuate within $0.00 to $33.34, with a midpoint forecast of $1.45. The stock might deliver a -78.00% loss.
August 2027
Forecasting for August 2027, models estimate that bioAffinity Technologies, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $30.33, averaging $1.29. This signals a cautious trajectory with potential returns around -80.42%.
September 2027
According to our latest forecast models, bioAffinity Technologies, Inc. (BIAF) is positioned to show a strong performance in September 2027. The price is predicted to move between $0.00 and $15.88, settling at an average of $0.65. This could translate to a -90.14% loss.
BIAF's history of dividends and stock splits also plays a role in long-term investor confidence.